Protein regulators of G protein signaling (RGS proteins) were discovered as negative regulators of heterotrimeric G protein-mediated signal transduction in yeast and worms. Experiments with purified recombinant proteins in vitro have established that RGS proteins accelerate the GTPase activity of certain G protein ␣ subunits (the reaction responsible for their deactivation); they can also act as effector antagonists. We demonstrate herein that either of two such RGS proteins, RGS4 or GAIP, attenuated signal transduction mediated by endogenous receptors, G proteins, and effectors when stably expressed as tagged proteins in transfected mammalian cells. The pattern of selectivity observed in vivo was similar to that seen in vitro. RGS4 and GAIP both attenuated G i -mediated inhibition of cAMP synthesis. RGS4 was more effective than GAIP in blocking G q -mediated activation of phospholipase C.A family of guanine nucleotide-binding regulatory proteins (G proteins) transduces signals across the plasma membrane by sequential interactions with cell surface receptors and appropriate effectors (e.g., enzymes and ion channels; reviewed in ref. 1). These interactions are modulated by nucleotide-driven conformational changes in the ␣ subunits of heterotrimeric G proteins. A ligand-bound receptor catalyzes the exchange of GDP for GTP on the ␣ subunit of its cognate G protein, and the ensuing conformational change in the ␣ subunit promotes its dissociation from the complex of  and ␥ subunits. These dissociated subunits are then competent to modulate the activity of effectors. The intrinsic GTPase activity of ␣ serves as a molecular clock, returning the protein to the GDP-bound state and allowing reformation of the heterotrimer.The intrinsic GTPase activities of ␣ subunits measured in vitro cannot, in many cases, account for the rapid termination of signaling that occurs in vivo. The discovery of a novel family of regulators of G protein signaling (RGS proteins) has provided a model that can help explain this discrepancy because members of this family have recently been shown to accelerate the GTPase activity of certain ␣ subunits (reviewed in ref.2). Patterns of specificity between individual RGS proteins and subfamilies of G protein ␣ subunits are only beginning to emerge. Among these, GAIP and RGS4 can serve as GTPase-activating proteins (GAPs) for the G i and G q but not the G s or G 12 subfamilies of ␣ subunits (3-7). To date, such studies have largely been limited to proteins produced and purified from Escherichia coli and assayed in vitro. These proteins may lack relevant covalent modifications or they may (at high concentrations) display properties that are irrelevant for intact cells. We sought to determine if stable expression of GAIP or RGS4 in HEK293 cells would negatively regulate their endogenous signaling pathways in ways that would be anticipated from the GAP activities of these two RGS proteins in vitro.